LONDON--(BUSINESS WIRE)--Edison Investment Research, a UK-based independent equity research firm, announces the initiation of research coverage on Transgene (NYSE Euronext Paris: TNG), a French immunotherapy drug discovery and development company.
LONDON--(BUSINESS WIRE)--Edison Investment Research, a UK-based independent equity research firm, announces the initiation of research coverage on Transgene (NYSE Euronext Paris: TNG), a French immunotherapy drug discovery and development company.
